Updated
For as long as most doctors can remember, the female ovary was set to expire one day. Indeed, once a woman went through menopause and her fertile years were over, the organ was considered finished—a spent shell that had done its job. In fact, one of the nation’s leading reproductive biologists, Francesca Duncan of Northwestern…Continue reading Second Act: What Happens to the Ovary After Menopause?
Updated
We’ve all seen a dog asleep on the kitchen floor while its owner cooks dinner. This image is one of the most ordinary scenes in American life. According to research, for dogs, it is also a slow, steady exposure to industrial chemicals that we often don’t think about when it comes to our four-legged family. Our beloved…Continue reading The Canary on the Kitchen Floor
Updated
A new structure is popping up across the United States, and most of us have never heard the name of it. The massive compound is called a frontier AI data center, a term coined as a legal category by the Biden administration in January 2025, and it represents nothing less than an unprecedented computer empire.…Continue reading Public Land, Private AI Empires
A study conducted on the effectiveness of the bivalent COVID-19 vaccine has surprised many at the Cleveland Clinic. The organization studied its employees to determine how the new bivalent vaccines stack up against some of the more prevalent COVID strains in circulation. The results weren’t what they expected. The study’s authors admit their surprise that…Continue reading Cleveland Clinic: More Boosters? More Likely to Get COVID-19
Updated
A triad of alarming events is happening alongside each other, interlaced with desperation for society to pay closer attention to people in need and the dangers of antidepressants. The failed pandemic response caused job loss and incomes to freefall for middle-class Americans. Those lower-income individuals were hit the hardest. The Great Barrington Declaration, whose authors and…Continue reading REVISITING ANTIDEPRESSANT DRUG DANGERS IN A POST-COVID WORLD
Updated
At the ReSViNET Conference in Lisbon, Portugal, in February 2023, GSK Vice President of Vaccine Development Ilse Dieussaert discloses why GSK abandoned its maternal RSVPreF3 vaccine trial last February. The study was a phase 3, double-blinded, saline placebo-controlled trial with participants across 24 different high and low-middle-income countries. The pregnant women were followed up to…Continue reading How GSK’s RSV Vaccine Safety Signal Opens Up Investigation for All Maternal Vaccines
Updated
In a measure that is no doubt devised as a desperate attempt to hold tight to its grasp as the self-proclaimed arbiter of global pandemics, the World Health Organization just launched a new pandemic prevention plan. Released on April 27, 2023, the WHO’s Preparedness and Resilience for Emerging Threats (PRET) Initiative’s first module focuses on…Continue reading WHO’s New Pandemic Prevention Plan: First Focus – Respiratory Pathogens
Updated
For Americans not yet convinced of Pfizer’s intentionally sinister role in the declining physical and mental health of our nation, the billion-dollar company’s behind-the-scenes funding of the test widely used for depression is another decisive example. Specifically, while searching in the late 1990s for ways to encourage primary care doctors to prescribe its newly-released antidepressant…Continue reading Pfizer-Funded, Decades-Old Mental Health Checklist Fueled SSRIs
Updated
Despite the blatant failure of the experimental mRNA COVID-19 injections—and the declaration by thousands of physicians around the world that natural immunity proves to be the most protective and longest-lasting solution against COVID-19—the Biden administration intends to use at least another $5 billion of taxpayer money to accelerate the development of new COVID vaccines and…Continue reading As Pandemic Officially Ends, Biden Keeps COVID Alive With Future Funding
Updated